A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes.
Zambrano P, Segura-Pacheco B, Perez-Cardenas E, Cetina L, Revilla-Vazquez A, Taja-Chayeb L, Chavez-Blanco A, Angeles E, Cabrera G, Sandoval K, Trejo-Becerril C, Chanona-Vilchis J, Duenas-González A.
Zambrano P, et al.
BMC Cancer. 2005 Apr 29;5:44. doi: 10.1186/1471-2407-5-44.
BMC Cancer. 2005.
PMID: 15862127
Free PMC article.
Clinical Trial.